Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Department of Pathology, Shenzhen People's Hospital, Shenzhen, China.
Histopathology. 2019 Sep;75(3):320-328. doi: 10.1111/his.13881. Epub 2019 Jul 16.
Atypical ductal hyperplasia (ADH) of breast is increasingly diagnosed in core needle biopsy (CNB). As higher-grade lesions were found in the excision in a substantial proportion of ADH on CNB, factors predicting risk of subsequent upgrade are clinically significant. This study aims to investigate relevant histopathological factors in CNB that could predict diagnostic upgrade at excision.
One hundred and forty-three cases of CNB with paired subsequent excision were evaluated for multiple clinicopathological parameters related to CNB sampling, ADH morphology, calcification and other co-existing histological features, and which of these parameters were associated with diagnostic upgrade at subsequent excisions were determined. Forty-eight cases (34.3%) were upgraded to malignancy, including 15 invasive cancers and 33 ductal carcinomas in situ (DCIS). An increased tissue area occupied by ADH (P = 0.026), a higher number of ADH foci (P = 0.004), the presence of solid pattern (P = 0.037) and older age (P = 0.012) were positively associated with upgrade, while negative associations were found with the presence of micropapillary pattern (P = 0.025), co-existing columnar cell lesions (CCL) (P = 0.001) and the presence of calcifications (P = 0.009). Multivariate logistic regression analysis showed that the number of ADH foci (HR = 2.810, P = 0.013) was an independent positive predictor, while co-existing CCL (HR = 0.391, P = 0.013) was an independent negative predictor for upgrade.
Patients with ADH in CNB showing the presence of co-existing CCL and a lower number of ADH foci have a lower risk of disease upgrade at excision, and are potential candidates for observation-only management.
乳腺非典型导管增生(ADH)在核心针活检(CNB)中越来越多地被诊断出来。由于在相当一部分 ADH 的 CNB 切除标本中发现了高级别病变,因此预测后续升级风险的因素在临床上具有重要意义。本研究旨在探讨 CNB 中与 ADH 相关的组织病理学因素,这些因素可预测切除时的诊断升级。
对 143 例 CNB 伴随后续切除的病例进行了评估,这些病例涉及与 CNB 取样、ADH 形态、钙化和其他共存组织学特征相关的多个临床病理参数,确定了这些参数中哪些与后续切除时的诊断升级有关。48 例(34.3%)升级为恶性肿瘤,包括 15 例浸润性癌和 33 例导管原位癌(DCIS)。ADH 所占组织面积增加(P=0.026)、ADH 灶数量增加(P=0.004)、存在实体模式(P=0.037)和年龄较大(P=0.012)与升级呈正相关,而存在微乳头状模式(P=0.025)、共存柱状细胞病变(CCL)(P=0.001)和存在钙化(P=0.009)则与升级呈负相关。多变量逻辑回归分析显示,ADH 灶数量(HR=2.810,P=0.013)是独立的阳性预测因子,而共存 CCL(HR=0.391,P=0.013)是升级的独立阴性预测因子。
在 CNB 中表现为共存 CCL 和 ADH 灶数量较少的 ADH 患者,在切除时发生疾病升级的风险较低,是仅观察管理的潜在候选者。